Navigation Links
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
Date:5/19/2009

Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Laval, Quebec (PRWEB) May 18, 2009 -- Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Validapro Biosciences Inc. via its division Laborium Biopharma will utilize the clinical scale bioproduction site for research and development projects as well as for commercial applications.

This agreement demonstrates the will of Validapro Biosciences Inc. to pursue its corporative growth strategy by the development of its Global Services Center to meet the needs of the Life Sciences industry. This represents phase 2 of the creation of its clinical biomanufacturing unit operating under the strictest regulatory requirements. Through this agreement, Universite de Montreal as well as its researchers and partners, get access to these services meeting the international standards.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2433924.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1

Related biology technology :

1. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
2. Immtech to Present at The Bank of Montreal Healthcare Conference
3. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
4. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
5. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
6. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
7. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
8. Neurocrine Biosciences Reports First Quarter 2009 Results
9. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
10. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
11. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):